{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:17:50Z","timestamp":1779167870916,"version":"3.51.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["480946"],"award-info":[{"award-number":["480946"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03984-w","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:05:25Z","timestamp":1775711125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated clinical and postmortem profiling in schizophrenia reveals a cognitive subtype linked to cerebrovascular disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0680-3141","authenticated-orcid":false,"given":"N. Catie","family":"Futhey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8273-8820","authenticated-orcid":false,"given":"Fidel","family":"Vila-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn J.","family":"Stochmanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7628-5108","authenticated-orcid":false,"given":"William G.","family":"Honer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Arranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4577-2106","authenticated-orcid":false,"given":"Belen","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Escanilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9rica","family":"Vera-Montecinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8275-7362","authenticated-orcid":false,"given":"Mark S.","family":"Cembrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-871X","authenticated-orcid":false,"given":"Veronica","family":"Hirsch-Reinshagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"3984_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1176\/ajp.153.3.321","volume":"153","author":"MF Green","year":"1996","unstructured":"Green MF. What are the functional consequences of neurocognitive deficits in schizophrenia?. Am J Psychiatry. 1996;153:321\u201330.","journal-title":"Am J Psychiatry"},{"key":"3984_CR2","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, et al. Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019. Mol Psychiatry. 2023;28:5319\u201327.","journal-title":"Mol Psychiatry"},{"key":"3984_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1176\/appi.ajp.159.7.1183","volume":"159","author":"R Fuller","year":"2002","unstructured":"Fuller R, Nopoulos P, Arndt S, O\u2019Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002;159:1183\u20139.","journal-title":"Am J Psychiatry"},{"key":"3984_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.schres.2011.10.015","volume":"134","author":"SM August","year":"2012","unstructured":"August SM, Kiwanuka JN, McMahon RP, Gold JM. The MATRICS consensus cognitive battery (MCCB): clinical and cognitive correlates. Schizophr Res. 2012;134:76\u201382.","journal-title":"Schizophr Res"},{"key":"3984_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2013.155","volume":"70","author":"RS Kahn","year":"2013","unstructured":"Kahn RS, Keefe RSE. Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry. 2013;70:1107\u201312.","journal-title":"JAMA Psychiatry"},{"key":"3984_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2009.09040574","volume":"167","author":"A Reichenberg","year":"2010","unstructured":"Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RSE, Murray RM, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry. 2010;167:160\u20139.","journal-title":"Am J Psychiatry"},{"key":"3984_CR7","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/schbul\/sbm140","volume":"34","author":"B Kirkpatrick","year":"2008","unstructured":"Kirkpatrick B, Messias E, Harvey PD, Fernandez-Egea E, Bowie CR. Is schizophrenia a syndrome of accelerated aging?. Schizophr Bull. 2008;34:1024\u201332.","journal-title":"Schizophr Bull"},{"key":"3984_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2012.10.033","volume":"143","author":"WK Thompson","year":"2013","unstructured":"Thompson WK, Savla GN, Vahia IV, Depp CA, O\u2019Hara R, Jeste DV, et al. Characterizing trajectories of cognitive functioning in older adults with schizophrenia: Does method matter?. Schizophr Res. 2013;143:90\u20136.","journal-title":"Schizophr Res"},{"key":"3984_CR9","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","volume":"28","author":"RA McCutcheon","year":"2023","unstructured":"McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry. 2023;28:1902\u201318.","journal-title":"Mol Psychiatry"},{"key":"3984_CR10","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2022.2315","volume":"65","author":"A Vita","year":"2022","unstructured":"Vita A, Gaebel W, Mucci A, Sachs G, Barlati S, Giordano GM, et al. European psychiatric association guidance on treatment of cognitive impairment in schizophrenia. Eur Psychiatry J Assoc Eur Psychiatr. 2022;65:e57.","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"3984_CR11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00406-022-01416-6","volume":"272","author":"Y Gebreegziabhere","year":"2022","unstructured":"Gebreegziabhere Y, Habatmu K, Mihretu A, Cella M, Alem A. Cognitive impairment in people with schizophrenia: an umbrella review. Eur Arch Psychiatry Clin Neurosci. 2022;272:1139\u201355.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3984_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.31887\/DCNS.2019.21.3\/amccleery","volume":"21","author":"A McCleery","year":"2019","unstructured":"McCleery A, Nuechterlein KH. Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations. Dialogues Clin Neurosci. 2019;21:239\u201348.","journal-title":"Dialogues Clin Neurosci"},{"key":"3984_CR13","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s00406-019-01073-2","volume":"270","author":"S Kogan","year":"2020","unstructured":"Kogan S, Ospina LH, Mittal VA, Kimhy D. The impact of inflammation on neurocognition and risk for psychosis: a critical review. Eur Arch Psychiatry Clin Neurosci. 2020;270:793\u2013802.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3984_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"3984_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/00002093-199408040-00001","volume":"8","author":"HM Wisniewski","year":"1994","unstructured":"Wisniewski HM, Constantinidis J, Wegiel J, Bobinski M, Tarnawski M. Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis Assoc Disord. 1994;8:211\u201327.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3984_CR16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/schbul\/19.4.805","volume":"19","author":"I Prohovnik","year":"1993","unstructured":"Prohovnik I, Dwork AJ, Kaufman MA, Willson N. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull. 1993;19:805\u201316.","journal-title":"Schizophr Bull"},{"key":"3984_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/brain\/122.4.593","volume":"122","author":"PJ Harrison","year":"1999","unstructured":"Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain J Neurol. 1999;122:593\u2013624.","journal-title":"Brain J Neurol"},{"key":"3984_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0006-3223(97)00031-0","volume":"43","author":"GM Murphy","year":"1998","unstructured":"Murphy GM, Lim KO, Wieneke M, Ellis WG, Forno LS, Hoff AL, et al. No neuropathologic evidence for an increased frequency of Alzheimer\u2019s disease among elderly schizophrenics. Biol Psychiatry. 1998;43:205\u20139.","journal-title":"Biol Psychiatry"},{"key":"3984_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archpsyc.55.3.225","volume":"55","author":"SE Arnold","year":"1998","unstructured":"Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry. 1998;55:225\u201332.","journal-title":"Arch Gen Psychiatry"},{"key":"3984_CR20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1176\/ajp.154.6.861","volume":"154","author":"RJ Baldessarini","year":"1997","unstructured":"Baldessarini RJ, Hegarty JD, Bird ED, Benes FM. Meta-analysis of postmortem studies of Alzheimer\u2019s disease-like neuropathology in schizophrenia. Am J Psychiatry. 1997;154:861\u20133.","journal-title":"Am J Psychiatry"},{"key":"3984_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0920-9964(98)00028-0","volume":"31","author":"K Niizato","year":"1998","unstructured":"Niizato K, Arai T, Kuroki N, Kase K, Iritani S, Ikeda K. Autopsy study of Alzheimer\u2019s disease brain pathology in schizophrenia. Schizophr Res. 1998;31:177\u201384.","journal-title":"Schizophr Res"},{"key":"3984_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0006-3223(93)90291-K","volume":"33","author":"DP Purohit","year":"1993","unstructured":"Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, et al. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry. 1993;33:255\u201360.","journal-title":"Biol Psychiatry"},{"key":"3984_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1001\/archpsyc.55.3.205","volume":"55","author":"DP Purohit","year":"1998","unstructured":"Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Arch Gen Psychiatry. 1998;55:205\u201311.","journal-title":"Arch Gen Psychiatry"},{"key":"3984_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0197-4580(94)90024-8","volume":"15","author":"SE Arnold","year":"1994","unstructured":"Arnold SE, Franz BR, Trojanowski JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging. 1994;15:299\u2013303.","journal-title":"Neurobiol Aging"},{"key":"3984_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0165-1781(93)90029-G","volume":"49","author":"MF Casanova","year":"1993","unstructured":"Casanova MF, Carosella NW, Gold JM, Kleinman JE, Weinberger DR, Powers RE. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer\u2019s disease and cognitively impaired patients with schizophrenia. Psychiatry Res. 1993;49:41\u201362.","journal-title":"Psychiatry Res"},{"key":"3984_CR26","doi-asserted-by":"publisher","first-page":"e301017","DOI":"10.1136\/bmjment-2024-301017","volume":"27","author":"JC Wilson","year":"2024","unstructured":"Wilson JC, Liu KY, Jones K, Mahmood J, Arya U, Howard R. Biomarkers of neurodegeneration in schizophrenia: systematic review and meta-analysis. BMJ Ment Health. 2024;27:e301017.","journal-title":"BMJ Ment Health"},{"key":"3984_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00401-009-0492-5","volume":"117","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA. Lewy body\/\u03b1-synucleinopathy in schizophrenia and depression: a preliminary neuropathological study. Acta Neuropathol (Berl). 2009;117:423\u20137.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3984_CR28","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1176\/ajp.153.10.1274","volume":"153","author":"M Davidson","year":"1996","unstructured":"Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer\u2019s disease. Am J Psychiatry. 1996;153:1274\u20139.","journal-title":"Am J Psychiatry"},{"key":"3984_CR29","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/STR.0000000000000431","volume":"54","author":"C Iadecola","year":"2023","unstructured":"Iadecola C, Smith EE, Anrather J, Gu C, Mishra A, Misra S, et al. The neurovasculome: key roles in brain health and cognitive impairment: a scientific statement from the American heart association\/American stroke association. Stroke. 2023;54:e251\u201371.","journal-title":"Stroke"},{"key":"3984_CR30","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.mayocp.2020.01.028","volume":"95","author":"J Graff-Radford","year":"2020","unstructured":"Graff-Radford J, Aakre JA, Knopman DS, Schwarz CG, Flemming KD, Rabinstein AA, et al. Prevalence and heterogeneity of cerebrovascular disease imaging lesions. Mayo Clin Proc. 2020;95:1195\u2013205.","journal-title":"Mayo Clin Proc"},{"key":"3984_CR31","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","volume":"36","author":"L Raz","year":"2016","unstructured":"Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. 2016;36:172\u201386.","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"key":"3984_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2010.08.039","volume":"299","author":"I Ferrer","year":"2010","unstructured":"Ferrer I. Cognitive impairment of vascular origin: neuropathology of cognitive impairment of vascular origin. J Neurol Sci. 2010;299:139\u201349.","journal-title":"J Neurol Sci"},{"key":"3984_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/jamaneurol.2022.5416","volume":"80","author":"F Grodstein","year":"2023","unstructured":"Grodstein F, Leurgans SE, Capuano AW, Schneider JA, Bennett DA. Trends in postmortem neurodegenerative and cerebrovascular neuropathologies over 25 years. JAMA Neurol. 2023;80:370\u20136.","journal-title":"JAMA Neurol"},{"key":"3984_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1474-4422(17)30196-5","volume":"16","author":"Veluw","year":"2017","unstructured":"Veluw, van SJ, Shih AY, Smith EE, Chen C, Schneider JA, et al. Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol. 2017;16:730\u201340.","journal-title":"Lancet Neurol"},{"key":"3984_CR35","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the national Alzheimer\u2019s coordinating centre. Brain. 2013;136:2697\u2013706.","journal-title":"Brain"},{"key":"3984_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0206-2","volume":"12","author":"J Attems","year":"2014","unstructured":"Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer\u2019s disease - lessons from pathology. BMC Med. 2014;12:206.","journal-title":"BMC Med"},{"key":"3984_CR37","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71:362\u201381.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3984_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ana.10161","volume":"51","author":"KP Riley","year":"2002","unstructured":"Riley KP, Snowdon DA, Markesbery WR. Alzheimer\u2019s neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 2002;51:567\u201377.","journal-title":"Ann Neurol"},{"key":"3984_CR39","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/ana.21009","volume":"60","author":"HC Chui","year":"2006","unstructured":"Chui HC, Zarow C, Mack WJ, Ellis WG, Zheng L, Jagust WJ, et al. Cognitive impact of subcortical vascular and Alzheimer\u2019s disease pathology. Ann Neurol. 2006;60:677\u201387.","journal-title":"Ann Neurol"},{"key":"3984_CR40","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1002\/alz.12516","volume":"18","author":"D Godrich","year":"2022","unstructured":"Godrich D, Martin ER, Schellenberg G, Pericak-Vance MA, Cuccaro M, Scott WK, et al. Neuropathological lesions and their contribution to dementia and cognitive impairment in a heterogeneous clinical population. Alzheimers Dement. 2022;18:2403\u201312.","journal-title":"Alzheimers Dement"},{"key":"3984_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5414\/NP300512","volume":"31","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Gelpi E. Clinical neuropathology practice news 3-2012: the \u201cABC\u201d in AD \u2013 revised and updated guideline for the neuropathologic assessment of Alzheimer\u2019s disease. Clin Neuropathol. 2012;31:116\u20138.","journal-title":"Clin Neuropathol"},{"key":"3984_CR42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13195-023-01289-4","volume":"15","author":"M Lee","year":"2023","unstructured":"Lee M, Yeo NY, Ahn HJ, Lim JS, Kim Y, Lee SH, et al. Prediction of post-stroke cognitive impairment after acute ischemic stroke using machine learning. Alzheimers Res Ther. 2023;15:147.","journal-title":"Alzheimers Res Ther"},{"key":"3984_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National institute on aging-alzheimer\u2019s association guidelines for the neuropathologic assessment of alzheimer\u2019s disease: a practical approach. Acta Neuropathol (Berl). 2012;123:1\u201311.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3984_CR44","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/brain\/aww214","volume":"139","author":"OA Skrobot","year":"2016","unstructured":"Skrobot OA, Attems J, Esiri M, Hortob\u00e1gyi T, Ironside JW, Kalaria RN, et al. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain J Neurol. 2016;139:2957\u201369.","journal-title":"Brain J Neurol"},{"key":"3984_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.biopsych.2010.08.027","volume":"69","author":"TP Schnieder","year":"2011","unstructured":"Schnieder TP, Dwork AJ. Searching for neuropathology: Gliosis in schizophrenia. Biol Psychiatry. 2011;69:134\u20139.","journal-title":"Biol Psychiatry"},{"key":"3984_CR46","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1176\/ajp.152.5.731","volume":"152","author":"SE Arnold","year":"1995","unstructured":"Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gibney MR, et al. Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. Am J Psychiatry. 1995;152:731\u20137.","journal-title":"Am J Psychiatry"},{"key":"3984_CR47","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.euroneuro.2018.12.011","volume":"29","author":"I L\u00f3pez-Gonz\u00e1lez","year":"2019","unstructured":"L\u00f3pez-Gonz\u00e1lez I, Pinacho R, Vila \u00c8, Escanilla A, Ferrer I, Ramos B. Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia. Eur Neuropsychopharmacol. 2019;29:384\u201396.","journal-title":"Eur Neuropsychopharmacol"},{"key":"3984_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1134-5934(08)71126-6","volume":"15","author":"M Roca Casas\u00fas","year":"2008","unstructured":"Roca Casas\u00fas M, Escanilla Casal A, Monje Hern\u00e1ndez A, Ba\u00f1o Galindo V, Planchat Teruel LM, Costa Escola J, et al. Banco de tejidos neurol\u00f3gicos de Sant Joan de D\u00e9u-Serveis de Salut Mental para la investigaci\u00f3n de las enfermedades mentales. La importancia de un programa de donaci\u00f3n en vida. Psiquiatr Biol\u00f3gica. 2008;15:73\u20139.","journal-title":"Psiquiatr Biol\u00f3gica"},{"key":"3984_CR49","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686\u201393.","journal-title":"Am J Psychiatry"},{"key":"3984_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"3984_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1590\/S1980-57642010DN40100006","volume":"4","author":"R Kochhann","year":"2010","unstructured":"Kochhann R, Varela JS, Lisboa CSM, Chaves MLF. The mini mental state examination: review of cutoff points adjusted for schooling in a large Southern Brazilian sample. Dement Neuropsychol. 2010;4:35\u201341.","journal-title":"Dement Neuropsychol"},{"key":"3984_CR52","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1212\/WNL.38.10.1565","volume":"38","author":"ML Bleecker","year":"1988","unstructured":"Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the mini-mental state exam. Neurology. 1988;38:1565\u20138.","journal-title":"Neurology"},{"key":"3984_CR53","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922\u201335.","journal-title":"J Am Geriatr Soc"},{"key":"3984_CR54","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/00005053-199008000-00007","volume":"178","author":"SR Kay","year":"1990","unstructured":"Kay SR, Fiszbein A, Vital-Herne M, Fuentes LS. The positive and negative syndrome scale\u2014Spanish adaptation. J Nerv Ment Dis. 1990;178:510.","journal-title":"J Nerv Ment Dis"},{"key":"3984_CR55","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB. Neurology. 2000;55:1621\u20136.","journal-title":"Neurology"},{"key":"3984_CR56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.33588\/rn.3607.2002363","volume":"36","author":"A Rodriguez del Alamo","year":"2003","unstructured":"Rodriguez del Alamo A, Catal\u00e1n Alonso MJ, Carrasco Mar\u00edn L. [FAB: a preliminar Spanish application of the frontal assessment battery to 11 groups of patients]. Rev Neurol. 2003;36:605\u20138.","journal-title":"Rev Neurol"},{"key":"3984_CR57","first-page":"767","volume":"112","author":"A Lobo","year":"1999","unstructured":"Lobo A, Saz P, Marcos G, D\u00eda JL, de la C\u00e1mara C, Ventura T, et al. [Revalidation and standardization of the cognition mini-exam (first Spanish version of the mini-mental status examination) in the general geriatric population]. Med Clin (Barc). 1999;112:767\u201374.","journal-title":"Med Clin (Barc)"},{"key":"3984_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (Berl). 2014;128:755\u201366.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3984_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40478-021-01233-3","volume":"9","author":"MA Iida","year":"2021","unstructured":"Iida MA, Farrell K, Walker JM, Richardson TE, Marx GA, Bryce CH, et al. Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study. Acta Neuropathol Commun. 2021;9:134.","journal-title":"Acta Neuropathol Commun"},{"key":"3984_CR60","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/jnen\/nlad064","volume":"82","author":"M Morris","year":"2023","unstructured":"Morris M, Coste GI, Redding-Ochoa J, Guo H, Graves AR, Troncoso JC, et al. Hippocampal synaptic alterations associated with tau pathology in primary age-related tauopathy. J Neuropathol Exp Neurol. 2023;82:836\u201344.","journal-title":"J Neuropathol Exp Neurol"},{"key":"3984_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1161\/STROKEAHA.121.034814","volume":"53","author":"M Lamar","year":"2022","unstructured":"Lamar M, Leurgans S, Kapasi A, Barnes LL, Boyle PA, Bennett DA, et al. Complex profiles of cerebrovascular disease pathologies in the aging brain and their relationship with cognitive decline. Stroke. 2022;53:218\u201327.","journal-title":"Stroke"},{"key":"3984_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v106.i01","volume":"106","author":"JK Tay","year":"2023","unstructured":"Tay JK, Narasimhan B, Hastie T. Elastic net regularization paths for all generalized linear models. J Stat Softw. 2023;106:1\u201331.","journal-title":"J Stat Softw"},{"key":"3984_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1\u201367.","journal-title":"J Stat Softw"},{"key":"3984_CR64","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/PAF.0b013e31823d29ad","volume":"33","author":"DK Molina","year":"2012","unstructured":"Molina DK, DiMaio VJM. Normal organ weights in men: part II-the brain, lungs, liver, spleen, and kidneys. Am J Forensic Med Pathol. 2012;33:368\u201372.","journal-title":"Am J Forensic Med Pathol"},{"key":"3984_CR65","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","volume":"56","author":"MF Green","year":"2004","unstructured":"Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry. 2004;56:301\u20137.","journal-title":"Biol Psychiatry"},{"key":"3984_CR66","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1038\/s41380-022-01731-3","volume":"27","author":"J Seitz-Holland","year":"2022","unstructured":"Seitz-Holland J, Wojcik JD, Cetin-Karayumak S, Lyall AE, Pasternak O, Rathi Y, et al. Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study. Mol Psychiatry. 2022;27:3719\u201330.","journal-title":"Mol Psychiatry"},{"key":"3984_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01049-0","volume":"10","author":"M Yang","year":"2020","unstructured":"Yang M, Gao S, Zhang X. Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia. Transl Psychiatry. 2020;10:1\u20138.","journal-title":"Transl Psychiatry"},{"key":"3984_CR68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pscychresns.2015.08.008","volume":"234","author":"D Geisler","year":"2015","unstructured":"Geisler D, Walton E, Naylor M, Roessner V, Lim KO, Schulz SC, et al. Brain structure and function correlates of cognitive subtypes in schizophrenia. Psychiatry Res. 2015;234:74\u201383.","journal-title":"Psychiatry Res"},{"key":"3984_CR69","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neubiorev.2019.09.006","volume":"107","author":"SP Carruthers","year":"2019","unstructured":"Carruthers SP, Van Rheenen TE, Gurvich C, Sumner PJ, Rossell SL. Characterising the structure of cognitive heterogeneity in schizophrenia spectrum disorders. A systematic review and narrative synthesis. Neurosci Biobehav Rev. 2019;107:252\u201378.","journal-title":"Neurosci Biobehav Rev"},{"key":"3984_CR70","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","volume":"6","author":"J Rahimi","year":"2014","unstructured":"Rahimi J, Kovacs GG. Prevalence of mixed pathologies in the aging brain. Alzheimers Res Ther. 2014;6:82.","journal-title":"Alzheimers Res Ther"},{"key":"3984_CR71","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s00415-006-0251-7","volume":"253","author":"H Oguro","year":"2006","unstructured":"Oguro H, Yamaguchi S, Abe S, Ishida Y, Bokura H, Kobayashi S. Differentiating Alzheimer\u2019s disease from subcortical vascular dementia with the FAB test. J Neurol. 2006;253:1490\u20134.","journal-title":"J Neurol"},{"key":"3984_CR72","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1080\/00207450590957953","volume":"115","author":"Z Golden","year":"2005","unstructured":"Golden Z, Bouvier M, Selden J, Mattis K, Todd M, Golden C. Differential performance of Alzheimer\u2019s and vascular dementia patients on a brief battery of neuropsychological tests. Int J Neurosci. 2005;115:1569\u201377.","journal-title":"Int J Neurosci"},{"key":"3984_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/archpsyc.1986.01800010038005","volume":"43","author":"R Brown","year":"1986","unstructured":"Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, et al. Postmortem evidence of structural brain changes in schizophrenia: differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry. 1986;43:36\u201342.","journal-title":"Arch Gen Psychiatry"},{"key":"3984_CR74","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1161\/STROKEAHA.110.595181","volume":"41","author":"MMF Poels","year":"2010","unstructured":"Poels MMF, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds. Stroke. 2010;41:S103\u20136.","journal-title":"Stroke"},{"key":"3984_CR75","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00401-022-02527-z","volume":"145","author":"S Oveisgharan","year":"2023","unstructured":"Oveisgharan S, Kim N, Agrawal S, Yu L, Leurgans S, Kapasi A, et al. Brain and spinal cord arteriolosclerosis and its associations with cerebrovascular disease risk factors in community-dwelling older adults. Acta Neuropathol (Berl). 2023;145:219\u201333.","journal-title":"Acta Neuropathol (Berl)"},{"key":"3984_CR76","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/oxfordjournals.schbul.a033330","volume":"24","author":"P Powchik","year":"1998","unstructured":"Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, et al. Postmortem studies in schizophrenia. Schizophr Bull. 1998;24:325\u201341.","journal-title":"Schizophr Bull"},{"key":"3984_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.115713","volume":"332","author":"RST Chu","year":"2024","unstructured":"Chu RST, Chong RCH, Chang DHH, Shan Leung AL, Chan JKN, Wong CSM, et al. The risk of stroke and post-stroke mortality in people with schizophrenia: A systematic review and meta-analysis study. Psychiatry Res. 2024;332:115713.","journal-title":"Psychiatry Res"},{"key":"3984_CR78","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/YIC.0000000000000153","volume":"32","author":"N Berrocal-Izquierdo","year":"2017","unstructured":"Berrocal-Izquierdo N, Bioque M, Bernardo M. Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?. Int Clin Psychopharmacol. 2017;32:80.","journal-title":"Int Clin Psychopharmacol"},{"key":"3984_CR79","doi-asserted-by":"publisher","first-page":"7698030","DOI":"10.1155\/2021\/7698030","volume":"2021","author":"JB Ding","year":"2021","unstructured":"Ding JB, Hu K. Cigarette smoking and schizophrenia: etiology, clinical, pharmacological, and treatment implications. Schizophr Res Treat. 2021;2021:7698030.","journal-title":"Schizophr Res Treat"},{"key":"3984_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/247486","volume":"2013","author":"T Murray-Thomas","year":"2013","unstructured":"Murray-Thomas T, Jones ME, Patel D, Brunner E, Shatapathy CC, Motsko S, et al. Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database. Cardiovasc Psychiatry Neurol. 2013;2013:247486.","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"3984_CR81","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jamapsychiatry.2021.0015","volume":"78","author":"K Hagi","year":"2021","unstructured":"Hagi K, Nosaka T, Dickinson D, Lindenmayer JP, Lee J, Friedman J, et al. Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2021;78:510\u20138.","journal-title":"JAMA Psychiatry"},{"key":"3984_CR82","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S2215-0366(16)30262-0","volume":"3","author":"BI Perry","year":"2016","unstructured":"Perry BI, McIntosh G, Weich S, Singh S, Rees K. The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis. Lancet Psychiatry. 2016;3:1049\u201358.","journal-title":"Lancet Psychiatry"},{"key":"3984_CR83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","volume":"74","author":"T Pillinger","year":"2017","unstructured":"Pillinger T, Beck K, Gobjila C, Donocik JG, Jauhar S, Howes OD. Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:261\u20139.","journal-title":"JAMA Psychiatry"},{"key":"3984_CR84","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fpsyt.2020.00256","volume":"11","author":"H Liu","year":"2020","unstructured":"Liu H, Sun Y, Zhang X, Li S, Hu D, Xiao L, et al. Integrated analysis of summary statistics to identify pleiotropic genes and pathways for the comorbidity of schizophrenia and cardiometabolic disease. Front Psychiatry. 2020;11:256.","journal-title":"Front Psychiatry"},{"key":"3984_CR85","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.schres.2014.03.015","volume":"155","author":"T Nemoto","year":"2014","unstructured":"Nemoto T, Niimura H, Ryu Y, Sakuma K, Mizuno M. Long-term course of cognitive function in chronically hospitalized patients with schizophrenia transitioning to community-based living. Schizophr Res. 2014;155:90\u20135.","journal-title":"Schizophr Res"},{"key":"3984_CR86","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/STROKEAHA.110.579888","volume":"41","author":"ST Pendlebury","year":"2010","unstructured":"Pendlebury ST, Cuthbertson FC, Welch SJV, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke. Stroke. 2010;41:1290\u20133.","journal-title":"Stroke"},{"key":"3984_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.schres.2022.02.006","volume":"241","author":"PP Oomen","year":"2022","unstructured":"Oomen PP, Gangadin SS, Begemann MJH, Visser E, Mandl RCW, Sommer IEC. The neurobiological characterization of distinct cognitive subtypes in early-phase schizophrenia-spectrum disorders. Schizophr Res. 2022;241:228\u201337.","journal-title":"Schizophr Res"},{"key":"3984_CR88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1176\/appi.ajp.2020.20020132","volume":"177","author":"KE Lewandowski","year":"2020","unstructured":"Lewandowski KE. Genetically, developmentally, and clinically distinct cognitive subtypes in schizophrenia: a tale of three trajectories. Am J Psychiatry. 2020;177:282\u20134.","journal-title":"Am J Psychiatry"},{"key":"3984_CR89","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41386-021-00963-1","volume":"46","author":"J Wenzel","year":"2021","unstructured":"Wenzel J, Haas SS, Dwyer DB, Ruef A, Oeztuerk OF, Antonucci LA, et al. Cognitive subtypes in recent onset psychosis: distinct neurobiological fingerprints?. Neuropsychopharmacology. 2021;46:1475\u201383.","journal-title":"Neuropsychopharmacology"},{"key":"3984_CR90","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/schbul\/sbaa157","volume":"47","author":"K Lim","year":"2021","unstructured":"Lim K, Smucny J, Barch DM, Lam M, Keefe RSE, Lee J. Cognitive subtyping in schizophrenia: a latent profile analysis. Schizophr Bull. 2021;47:712\u201321.","journal-title":"Schizophr Bull"},{"key":"3984_CR91","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00406-013-0463-7","volume":"264","author":"E Gilbert","year":"2014","unstructured":"Gilbert E, M\u00e9rette C, Jomphe V, \u00c9mond C, Rouleau N, Bouchard RH, et al. Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment. Eur Arch Psychiatry Clin Neurosci. 2014;264:333\u201343.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3984_CR92","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.bbih.2022.100459","volume":"22","author":"L Zhang","year":"2022","unstructured":"Zhang L, Lizano P, Guo B, Xu Y, Rubin LH, Hill SK, et al. Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disorders. Brain Behav Immun - Health. 2022;22:100459.","journal-title":"Brain Behav Immun - Health"},{"key":"3984_CR93","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/brain\/awaa025","volume":"143","author":"GB Chand","year":"2020","unstructured":"Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain J Neurol. 2020;143:1027\u201338.","journal-title":"Brain J Neurol"},{"key":"3984_CR94","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1017\/S0033291724000667","volume":"54","author":"C Luo","year":"2024","unstructured":"Luo C, Pi X, Zhang Q, Hu N, Xiao Y, Sweeney JA, et al. A subtype of schizophrenia patients with altered methylation level of genes related to immune cell activity. Psychol Med. 2024;54:2538\u201346.","journal-title":"Psychol Med"},{"key":"3984_CR95","doi-asserted-by":"publisher","first-page":"104257","DOI":"10.1016\/j.nbd.2018.08.016","volume":"131","author":"FC Nucifora","year":"2019","unstructured":"Nucifora FC, Woznica E, Lee BJ, Cascella N, Sawa A. Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives. Neurobiol Dis. 2019;131:104257.","journal-title":"Neurobiol Dis"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03984-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03984-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:04:46Z","timestamp":1779167086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03984-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3984"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03984-w","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was provided by all participants or their legal representative. This study and its experimental protocols were reviewed and approved by the University of British Columbia Clinical Research Ethics Board (CREB), Vancouver, Canada (H18-01587). All methods were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"FVR has received honoraria for participation in an advisory board for Allergan and is a volunteer director on the board of directors of the British Columbia Schizophrenia Society (unpaid). The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}